Conversely, individuals with either complete loss-of-function alleles (no detectable PCSK9 levels) or partial loss-of-function alleles (truncation or missense mutations) typically have a lifelong decrease in LDL-C (28–40%) and lower risk of CAD (~40–90%) (5–7). The gene discussed is PCSK9; the disease is coronary artery disorder.